Dublin, July 27, 2023 (GLOBE NEWSWIRE) -- The "PEComa - Epidemiology Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Perivascular epithelioid cell neoplasms (PEComas) are ...

Announcing a new article publication for BIO Integration journal. Hepatic perivascular epithelioid cell tumor (PEComa) is a rare tumor with malignant potential that is frequently misdiagnosed as ...

As a passionate dancer, Cristina enjoyed an active life of dancing jazz, musical theater, Latin and belly dancing for many years. However, after a routine visit to her doctor in 2013, Cristina’s world ...

After 3 years of follow-up in AMPECT trial, confirmed clinically meaningful overall response rate, including multiple patients with complete responses "The data published in JCO highlight the ...

Background: Malignant perivascular epitheliod cell tumor (PEComa) is a very rare entity composed of distinctive perivascular epitheliod cells with variable immunoreactivity for melanocytic and muscle ...

(RTTNews) - Aadi Bioscience, Inc. (AADI), a company focused on precision therapies, said on Tuesday that the U.S. Food and Drug Administration or FDA has approved FYARRO, sirolimus protein-bound ...

Dublin, Aug. 07, 2023 (GLOBE NEWSWIRE) -- The "PEComa - Market Insights, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The report provides ...

Efficacy of Low-Dose Interferon α2a 18 Versus 60 Months of Treatment in Patients With Primary Melanoma of ≥ 1.5 mm Tumor Thickness: Results of a Randomized Phase III DeCOG Trial Sarcomas are a ...

A pregnant woman who went in to have a golf ball-sized lump on her leg examined while pregnant was diagnosed with a rare and deadly form of cancer in 2023 Since then, Zoë Handscomb-Edwards has been ...

A phase II study of surufatinib in patients with osteosarcoma and soft tissue sarcoma who have experienced treatment failure with standard chemotherapy. This is an ASCO Meeting Abstract from the 2023 ...